This inventor holds 2 USPTO granted patents. Top assignee: Zeria Pharmaceutical Co., Ltd.. Active years: 2004-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2007
Title: Nobuo Kawase: Pharmaceutical Inventions and Patent Contributions.
Introduction
Nobuo Kawase is an inventor associated with Saitama, Japan, and Zeria Pharmaceutical Co., Ltd. His patent work focuses on pharmaceutical compounds and their potential applications.
Latest Patents
Kawase’s listed patents include “Benzylamine Derivative,” which describes a compound designed to provide satisfactory oral absorption and antagonistic activity against NK-1 or NK-2 receptors. The invention covers a benzylamine derivative represented by formula (1), or a salt of that compound.
His other listed patent, “Calcium Salts of 1,5-Benzodiazepine Derivatives, Process for Producing the Salts and Drugs Containing the Same,” concerns the salts, their production, and pharmaceutical products containing them. Kawase is credited with 2 patents.
Career Highlights
Kawase’s patent portfolio reflects work on medicinal chemistry, including receptor-targeting compounds and benzodiazepine derivatives. His listed company affiliation is Zeria Pharmaceutical Co., Ltd.
Collaborations
Kawase’s listed coworkers include Masakazu Murata and Nobuyuki Tanaka.
Conclusion
Nobuo Kawase’s two listed patents highlight his contributions to pharmaceutical inventions involving benzylamine and 1,5-benzodiazepine derivatives.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile